Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1215 |
|---|---|
| Identifier | NCT04469062 |
| Trial Title | A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Mirikizumab IV|DRUG: Mirikizumab SC|DRUG: Vedolizumab IV|DRUG: Placebo IV|DRUG: Placebo SC |
Participant Information
| Sponsor | Eli Lilly and Company |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2021-04-20 |
|---|---|
| Primary Completion Date | 2024-03-13 |
| Completion Date | 2024-06-05 |